CVS Health Corporation reported financial results for the fourth quarter and full year of 2024, highlighting challenges ...
BofA raised the firm’s price target on CVS Health (CVS) to $75 from $63 and keeps a Buy rating on the shares. Aetna can add $3-$4 per share of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback